Compositions and methods for nucleic acid extraction and purification
By using polyhedral rigid substrates to contact biological samples and adsorption and washing, the problem of DNA shearing during DNA extraction and purification is solved, and the stable separation of high molecular weight DNA and the integrity of sequencing information is improved.
Patent Information
- Application Number
- CN202380039090.2
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Priority Date
- 2022-05-18
- Filing Date
- 2023-05-17
- Publication Date
- 2024-12-06
AI Technical Summary
Existing DNA extraction and purification methods can easily lead to mechanical shearing of DNA during the process, resulting in a decrease in the yield of high-molecular-weight DNA molecules and the reduction in the integrity of sequencing information.
The polyhedral rigid substrate is used to contact the biological sample, and the nucleic acid is separated and the damage to DNA is reduced through adsorption and washing processes, and the shearing of DNA during extraction and purification is reduced using its regular shape and material properties.
It effectively reduces the shear damage of DNA, improves the yield of high molecular weight DNA and the integrity of sequencing information, and provides a more stable nucleic acid separation method.
Smart Images

Figure FT_1 
Figure FT_2 
Figure FT_3
Abstract
Description
Background Art
[0001] Many techniques for analyzing nucleic acids, such as characterizing nucleic acids by sequencing, rely heavily on the quality of the nucleic acids used as input for the analysis. Sample preparation typically includes the steps of tissue lysis, nucleic acid extraction and purification. Summary of the invention
[0002] Various aspects of the present disclosure relate to compositions and methods for extracting and / or purifying nucleic acids from biological samples. The present disclosure is based in part on a polyhedral rigid substrate that, when in contact with nucleic acids in a biological sample, interacts (e.g., adsorbs, binds, chelates, etc.) with large DNA molecules in the sample. The large DNA molecules that interact with the substrate can then be separated from the biological sample with less damage (e.g., DNA shearing) than previously utilized DNA extraction or purification methods.
[0003] Therefore, in some aspects, the present disclosure provides a method for isolating nucleic acids from a biological sample, the method comprising: obtaining a biological sample, the biological sample comprising nucleic acids; contacting the biological sample with a polyhedral rigid substrate; adsorbing the nucleic acids of the sample onto the polyhedral rigid substrate; washing the polyhedral rigid substrate to remove non-nucleic acid components of the biological sample; and releasing the nucleic acids from the polyhedral rigid substrate to produce nucleic acids isolated from the biological sample.
[0004] In some embodiments, the nucleic acid comprises DNA. In some embodiments, the DNA is genomic DNA (gDNA). In some embodiments, the nucleic acid comprises high molecular weight (HMW) DNA. In some embodiments, the HMW DNA comprises DNA of at least 30 kb in size. In some embodiments, the HMW DNA comprises DNA of at least 50 kb in size, at least 100 kb in size, at least 200 kb in size, at least 300 kb in size, at least 500 kb in size, or at least 1 Mb in size.
[0005] In some embodiments, the biological sample comprises a tissue sample, a blood sample, a tissue lysate or a cell lysate. In some embodiments, the tissue lysate or the cell lysate has been previously obtained from the biological sample.
[0006] In some embodiments, obtaining a biological sample comprises lysing cells or tissues of the biological sample to produce a cell lysate or a tissue lysate.
[0007] In some embodiments, the polyhedral rigid substrate comprises or consists of 4 to 50 faces. In some embodiments, the polyhedral rigid substrate comprises or consists of 12 faces. In some embodiments, the polyhedral rigid substrate forms a regular shape. In some embodiments, the polyhedral rigid substrate forms an irregular shape.
[0008] In some embodiments, the polyhedral rigid substrate forms a star shape. In some embodiments, the star shape is a regular star shape. In some embodiments, the star shape comprises five points. In some embodiments, each outer angle of the star shape is between 71 and 73 degrees (e.g., 71, 72, 73, or any angle therebetween). In some embodiments, each inner angle of each point of the star shape is between 53 and 56 degrees (e.g., 53, 54, 55, 56, or any angle therebetween, such as 54.3 degrees).
[0009] In some embodiments, each edge of the polyhedral rigid substrate is substantially smooth. In some embodiments, each face of the polyhedral rigid substrate is substantially smooth.
[0010] In some embodiments, the outer diameter of the polyhedral rigid substrate is between about 5 mm and about 7 mm in length. In some embodiments, the outer diameter of the polyhedral rigid substrate is 6 mm in length. In some embodiments, the thickness of the polyhedral rigid substrate is between 0.1 mm and 0.5 mm.
[0011] In some embodiments, the polyhedral rigid substrate comprises or consists of metal. In some embodiments, the metal comprises or consists of stainless steel. In some embodiments, the stainless steel is 304 stainless steel, 316 stainless steel, 420 stainless steel, or 440 stainless steel.
[0012] In some embodiments, adsorbing the nucleic acid of the sample onto the polyhedral rigid substrate comprises providing conditions under which the nucleic acid of the sample nucleates on the surface of the substrate and forms one or more nucleic acid aggregates. In some embodiments, the conditions comprise contacting the biological sample with isopropanol, spermine, water, or TE buffer.
[0013] In some embodiments, washing comprises centrifuging the biological sample after contacting the biological sample with a wash buffer. In some embodiments, washing comprises performing a washing step (e.g., contacting with a wash buffer, centrifuging, removing the wash buffer, etc.) more than once (e.g., 2, 3, 4, 5 times or more).
[0014] In some embodiments, the non-nucleic acid components removed from the biological sample comprise one or more proteins, RNA molecules, salts, carbohydrates, or other cellular debris.
[0015] In some embodiments, releasing the nucleic acid from the substrate comprises contacting the substrate with isopropanol, spermine, water, or TE buffer.
[0016] In some embodiments, the isolated nucleic acid comprises or consists of genomic DNA (gDNA). In some embodiments, the isolated nucleic acid comprises or consists of high molecular weight (HMW) DNA.
[0017] In some embodiments, the isolated HMW DNA comprises at least 30 kb. In some embodiments, the isolated nucleic acid comprises less sheared DNA compared to a nucleic acid preparation prepared according to a method utilizing a round-shaped solid substrate or bead.
[0018] In some aspects, the present disclosure provides a kit comprising: (a) a microcentrifuge tube; and (b) a polyhedral rigid substrate as described herein.
[0019] In some embodiments, the kit further comprises one or more buffers (e.g., lysis buffer, wash buffer, elution buffer, etc.). In some embodiments, the one or more buffers comprise spermine.
[0020] In some embodiments, the present disclosure provides a method for nucleic acid (e.g., DNA) sequencing, the method comprising: obtaining an isolated nucleic acid according to a method as described herein; and sequencing the isolated nucleic acid using a sequencing device (e.g., a sequencing device suitable for ultra-long read sequencing). BRIEF DESCRIPTION OF THE DRAWINGS
[0021] Figure 1 is a schematic diagram depicting one embodiment of a polyhedral rigid substrate as described in the present disclosure. The substrate comprises a regular star-shaped stainless steel substrate that binds to nucleic acids (e.g., DNA) present in a biological sample (e.g., a cell or tissue lysate). Unless otherwise indicated, Figure 1 All values shown are expressed in millimeters (mm).
[0022] Figure 2 Representative data indicating that when gDNA in a sample precipitates, it nucleates around a polyhedral rigid substrate (eg, a metal star) and aggregates at the surface of the substrate are shown.
[0023] Figure 3 A photograph indicating a pinch point formed by a circular substrate is shown. Such pinch points have been observed to facilitate shearing of DNA (eg, gDNA), allowing shorter DNA fragments to be isolated from biological samples.
[0024] Figure 4Shown are representative data indicating read length N50 from a sequencing run in which DNA library DNA was cleaned using the rigid multi-sided substrates (eg, metal star shapes) described herein. DETAILED DESCRIPTION
[0025] Various aspects of the present disclosure relate to compositions and methods for extracting and / or purifying nucleic acids from biological samples. The present disclosure is based in part on polyhedral rigid substrates that, when in contact with nucleic acids from a biological sample, interact (e.g., adsorb, bind, chelate, etc.) with the nucleic acids so that nucleic acids can be separated from the biological sample with less damage (e.g., DNA shearing) than previously utilized DNA extraction or purification methods.
[0026] Polyhedral rigid substrate
[0027] Sequencing very long DNA reads requires isolating large DNA molecules (e.g., high molecular weight (HMW) DNA) and preserving those DNA molecules through library preparation techniques. One challenge faced during the preservation of long DNA molecules is the shearing of the DNA during DNA extraction or DNA purification procedures. For example, vigorous pipetting, pipetting through narrow-bore (e.g., non-"wide-bore") pipette tips, and the use of certain substrates such as borosilicate beads contribute to the mechanical shearing of DNA. This shearing of template DNA results in a reduced yield of HMW DNA molecules, thereby reducing the integrity of the long-read sequencing information obtained from such DNA.
[0028] The present inventors have recognized and appreciated that nucleic acids (e.g., DNA) extracted or purified using substrates having a rigid configuration and certain non-circular geometries (e.g., a polyhedral shape such as a star shape) are less damaged (e.g., resulting in reduced shearing and / or allowing for longer DNA template molecules) than DNA extracted or purified using techniques employing beads or certain circular substrates (e.g., as disclosed in International Patent Publication No. WO 2015 / 020818).
[0029] The polyhedral rigid substrates described in the present disclosure also provide improved DNA extraction or purification relative to previously described flexible polyhedral substrates. For example, the rigid substrates described herein allow for recovery of semi-eluted DNA because the rigid substrates do not spin to the bottom of the microcentrifuge tube during centrifugation, as would happen with substrates made of less rigid materials.
[0030] As used herein, a "polyhedral" substrate refers to a three-dimensional substrate comprising four or more faces. Examples of polyhedral substrates include, but are not limited to, three-dimensional substrates having a prism shape, a pyramid shape, a cube shape, a tetrahedron shape, a pentahedron shape, a hexahedron shape, a heptahedron shape, an octahedron shape, a pentahedron shape, a dodecahedron shape, an icosahedron shape, and the like. In some embodiments, the polyhedral substrate comprises 4 to 50 (e.g., 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, or 50) faces. In some embodiments, the polyhedral substrate comprises 6 to 15 faces. In some embodiments, the polyhedral substrate comprises 12 faces.
[0031] The polyhedron can be a regular polyhedron (e.g., a highly symmetric, edge-transitive, vertex-transitive, and face-transitive polyhedron) or an irregular polyhedron (e.g., formed by polygons of different shapes where all elements are different).
[0032] In some embodiments, the polyhedron comprises a star-shaped polyhedron shape. A star-shaped polyhedron shape refers to a self-intersecting uniform polyhedron comprising star-shaped polygonal faces and / or star-shaped polygonal vertex figures. Examples of star-shaped polyhedron shapes include, but are not limited to, small star-shaped dodecahedrons, large icosahedrons, pentagonal prisms, pentagonal bipyramids, and star-shaped polyhedrons.
[0033] The number of points (also referred to as vertices) of a star-shaped polyhedron may vary. In some embodiments, the star-shaped polyhedron comprises or consists of 5 to 92 vertices. In some embodiments, the star-shaped polyhedron comprises 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81 8, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91 or 92 points or composed thereof.
[0034] The star-shaped polyhedron containing points (e.g., vertices) has an exterior angle and an interior angle. As used herein, an exterior angle refers to the angle between a point of a star (e.g., the end of a point or vertex) and an adjacent point of the star. An interior angle refers to the angle between the two sides of the angle of the point forming the star. The size of the angle of the interior angle or exterior angle of the star-shaped polyhedron can vary. In some embodiments, the range of the exterior angle between the points of the star-shaped polyhedron is about 71 degrees to 73 degrees (e.g., 71 degrees, 71.5 degrees, 72 degrees, 72.5 degrees, 73 degrees, or any angle therebetween). In some embodiments, each interior angle of each point of the star-shaped shape is between 53 degrees and 56 degrees (e.g., 53 degrees, 54 degrees, 55 degrees, 56 degrees, or any angle therebetween, such as 54.3 degrees).
[0035] The present disclosure is based in part on a polyhedral rigid substrate that is configured to fit within a container typically used for DNA extraction and / or purification without forming a pinch point in the container. Examples of such containers include, but are not limited to, microcentrifuge tubes (e.g., Eppendorf tubes, etc.), test tubes, and conical vials. In some embodiments, the microcentrifuge tube is a 2.0 mL microcentrifuge tube, a 1.5 mL microcentrifuge tube, a 0.5 mL microcentrifuge tube, or a 0.2 mL microcentrifuge tube. In some embodiments, the microcentrifuge tube is a 1.5 mL microcentrifuge tube.
[0036] As used herein, "pinch point" refers to the space between the contact points between the container wall and the solid substrate, which forms a channel through which nucleic acids (e.g., DNA) pass during DNA extraction or purification. Without wishing to be bound by any particular theory, the presence of pinch points in the container during DNA extraction or purification increases the shearing of DNA during such procedures. In some embodiments, the polyhedral rigid substrates described in the present disclosure are configured to fit in a microcentrifuge tube and form fewer pinch points (e.g., 1, 2, 3, 4, 5 or more pinch points) in the tube relative to a circular substrate (e.g., a substrate in contact with substantially all of the inner surface of the microcentrifuge tube).
[0037] In some embodiments, the outer diameter of the polyhedral rigid substrate is less than the widest inner diameter of the microcentrifuge tube. The outer diameter refers to the longest distance between the points (e.g., vertices) of the star-shaped polyhedron. In some embodiments, the outer diameter length of the polyhedral rigid substrate is between about 5 mm and about 7 mm (e.g., 5.0 mm, 5.2 mm, 5.5 mm, 5.8 mm, 6.0 mm, 6.3 mm, 6.6 mm, 7.0 mm, or any length therebetween). In some embodiments, the outer diameter length of the polyhedral rigid substrate is 6 mm.
[0038] The thickness (e.g., height) of the polyhedral substrate can vary. In some embodiments, the thickness of the polyhedral rigid substrate is between 0.1 mm and 0.5 mm. In some embodiments, the thickness of the polyhedral rigid substrate is 0.1 mm, 0.2 mm, 0.3 mm, 0.4 mm, or 0.5 mm.
[0039] The materials used to form the polyhedral rigid substrate can vary. Examples of materials include metals, certain polymers (e.g., plastics), silicates (e.g., borosilicate glass), etc. In some embodiments, the polyhedral rigid substrate does not include cellulose-based paper (e.g., filter paper). In some embodiments, the polyhedral rigid substrate comprises or consists of a metal. In some embodiments, the metal comprises or consists of stainless steel. Examples of stainless steel include, but are not limited to, 301, 302, 303, 304, 309, 316, 321, 408, 409, 410, 416, 420, 430, 440, and 630 stainless steel. In some embodiments, the stainless steel is 304 stainless steel, 316 stainless steel, 420 stainless steel, or 440 stainless steel. Methods for forming metal substrates are generally known and include, for example, punching, roll forming, extrusion, and bending forming.
[0040] The polyhedral rigid substrates described in the present disclosure are generally substantially smooth. The term "substantially smooth" refers to a substrate having a uniform and regular surface or consistency, without perceptible protrusions, lumps, indentations, burrs or sharp edges. In some embodiments, each edge of the polyhedral rigid substrate is substantially smooth. In some embodiments, each face of the polyhedral rigid substrate is substantially smooth.
[0041] The present disclosure is based in part on rigid polyhedral substrates. Rigid substrates generally refer to substrates that do not deform when subjected to mechanical stress or force. In some embodiments, the rigidity of the polyhedral substrate is higher than that of previously used DNA extraction substrates, such as borosilicate glass or cellulose filter paper. Rigidity can be measured in any conventional manner, such as using shear modulus. In some embodiments, the shear modulus of the substrate ranges from 20 to about 80 GPa (e.g., about 20, 30, 40, 50, 60, 70, or 80 GPa).
[0042] Biological samples
[0043] The methods described in the present disclosure can be used to extract and / or purify nucleic acids from any suitable sample. The sample can be a biological sample, such as a fluid sample or a tissue sample. The sample is preferably a fluid sample. The sample generally comprises a body fluid. The body fluid can be obtained from a human or an animal. The human or animal may be suffering from, suspected of suffering from, or at risk of disease. The sample can be urine, lymph, saliva, mucus, semen, or amniotic fluid, but preferably whole blood, plasma, or serum. Typically, the sample is derived from a human, but alternatively, the sample can be from another mammal, such as from commercially raised animals, such as horses, cattle, sheep, or pigs, or alternatively can be a pet, such as a cat or dog.
[0044] Alternatively, plant-derived samples are typically obtained from cash crops such as cereals, legumes, fruits or vegetables, for example wheat, barley, oats, rapeseed, corn, soybeans, rice, bananas, apples, tomatoes, potatoes, grapes, tobacco, beans, lentils, sugar cane, cocoa, cotton, tea or coffee.
[0045] The sample may be a non-biological sample. The non-biological sample is preferably a fluid sample. Examples of non-biological samples include surgical fluids, water, such as drinking water, sea water or river water, and laboratory test reagents.
[0046] The sample may be processed prior to the assay, for example by centrifugation or filtering out unwanted molecules or membranes of cells such as red blood cells. The sample may be measured immediately after it is obtained. The sample may also be stored prior to the assay, preferably at less than -70°C.
[0047] Nucleic Acids
[0048] In some aspects, the present disclosure relates to nucleic acids and nucleic acid sequences. A "nucleic acid" sequence refers to DNA or RNA (or a sequence encoded by DNA or RNA). In some embodiments, nucleic acids are separated. As used herein, with respect to nucleic acids, the term "separated" means separated from other non-nucleic acid components (such as proteins, organelles, cell debris, salts, buffers, etc.) by mechanical or chemical separation, cutting, gel separation, or any other suitable method. In some embodiments, DNA (e.g., HMW gDNA) is separated from proteins, RNA, and other cellular components using the methods described herein. Isolated nucleic acids can be substantially purified. For example, an isolated nucleic acid is substantially pure, even if it may account for a very small percentage of the material in the cell in which it is located.
[0049] In some embodiments, nucleic acids or isolated nucleic acids are referred to as "polynucleotides" or "oligonucleotides". The terms "polynucleotide" and "oligonucleotide" refer to nucleic acids comprising two or more units (e.g., nucleotides) connected by a phosphate-based backbone (e.g., a sugar-phosphate backbone), such as genomic DNA (gDNA), complementary DNA (cDNA), RNA (e.g., mRNA, shRNA, dsRNA, miRNA, tRNA, etc.), synthetic nucleic acids, and synthetic nucleic acid analogs. Polynucleotides (or oligonucleotides) can include natural or non-natural bases or combinations thereof, and natural or non-natural backbone bonds, such as phosphorothioate bonds, peptide nucleic acids (PNA), 2'-0-methyl-RNA, or combinations thereof.
[0050] Aspects of the present disclosure relate to methods for extracting and / or purifying large DNA molecules from a biological sample. In some embodiments, the biological sample comprises high molecular weight (HMW) DNA. In some embodiments, the HMW DNA comprises DNA of at least 30 kb in size. In some embodiments, the HMW DNA comprises DNA of at least 50 kb in size, DNA of at least 100 kb in size, DNA of at least 200 kb in size, DNA of at least 300 kb in size, DNA of at least 500 kb in size, or DNA of at least 1 Mb in size. In some embodiments, DNA of a size greater than 50 kb is referred to as ultra-high molecular weight (UHMW) DNA.
[0051] After extraction, the genomic DNA (e.g., isolated genomic DNA) can be fragmented. The DNA can be fragmented by any suitable method. For example, methods for fragmenting DNA are known in the art. Such methods can use a transposase, such as MuA transposase or a commercially available G-tube.
[0052] Nucleic acids (e.g., DNA) can be single-stranded or double-stranded. In some embodiments, a single-stranded polynucleotide comprises a polynucleotide sequence connected by a continuous backbone. In some embodiments, a single-stranded polynucleotide comprises a 5' portion (end or terminus) and a 3' portion (end or terminus). A single-stranded polynucleotide can be a sense strand or an antisense strand.
[0053] In some embodiments, nucleic acids (e.g., polynucleotides) are double-stranded. A double-stranded polynucleotide comprises a first (e.g., "sense") polynucleotide strand that hybridizes to a second polynucleotide ("antisense") strand along a complementary region between the two strands through hydrogen bonding between the nucleobases of each strand. Each strand of the double-stranded polynucleotide comprises a 5' portion and a 3' portion.
[0054] Nucleic acid extraction and purification
[0055] Aspects of the present disclosure relate to methods for isolating nucleic acids (e.g., DNA, such as gDNA or HMW DNA) from a biological sample, the methods comprising: obtaining a biological sample, the biological sample comprising nucleic acids; contacting the biological sample with a polyhedral rigid substrate; adsorbing the nucleic acids of the sample onto the polyhedral rigid substrate; washing the polyhedral rigid substrate to remove non-nucleic acid components of the biological sample; releasing the nucleic acids from the polyhedral rigid substrate to produce nucleic acids isolated from the biological sample.
[0056] Methods for extracting DNA from biological samples are known, and reagents and kits for doing so are commercially available. In some embodiments, DNA is extracted from a biological sample using a kit suitable for long-read or ultra-long-read DNA sequencing. Examples of kits for DNA extraction for long-read or ultra-long-read DNA sequencing include, but are not limited to, Monarch ® HMW DNA Extraction Kit (New England Biolabs, USA; neb.com / products / t3060-monarch-hmw-dna-extraction-kit-for-tissue#Product%20Information; accessed on May 17, 2022), Wizard ® HMW DNA extraction kit (Promega, WI, USA), QIAGEN MagAttract HMW DNA kit, etc. Additional examples of HMW DNA extraction techniques are described in, for example, U.S. Patent Application Publication No. US 2021-0054363 A1, the entire contents of which are incorporated herein by reference.
[0057] In certain embodiments, extracting DNA and / or RNA comprises lysing cells of the biological sample, and separating the DNA and / or RNA from other cellular components. Examples of methods for lysing cells include, but are not limited to, mechanical lysis, liquid homogenization, ultrasonic treatment, freeze-thaw, chemical lysis, alkaline lysis, and manual grinding.
[0058] Methods for extracting DNA include, but are not limited to, solution phase extraction methods and solid phase extraction methods. In some embodiments, the solution phase extraction method comprises an organic extraction method, such as a phenol chloroform extraction method. In some embodiments, the solution phase extraction method comprises a high salt concentration extraction method, such as a guanidine thiocyanate (GuTC) or guanidine hydrochloride (GuCl) extraction method. In some embodiments, the solution phase extraction method comprises an ethanol precipitation method. In some embodiments, the solution phase extraction method comprises an isopropanol precipitation method. In some embodiments, the solution phase extraction method comprises an ethidium bromide (EtBr)-cesium chloride (CsCl) gradient centrifugation method. In some embodiments, extracting DNA comprises a non-ionic detergent extraction method, such as a hexadecyltrimethylammonium bromide (CTAB) extraction method.
[0059] In some embodiments, the solid phase DNA extraction method comprises contacting a biological sample (e.g., a cell or tissue lysate containing DNA) with a polyhedral rigid substrate as described herein. In some embodiments, the contact comprises providing conditions for the nucleic acid of the sample to nucleate on the surface of the substrate and form one or more nucleic acid aggregates. For example, certain DNA precipitants (e.g., isopropanol, spermine, water, TE buffer, etc.) are added to the cell lysate so that the DNA in the sample is precipitated and aggregated on the surface of the polyhedral rigid substrate. Without wishing to be bound by any particular theory, the polyhedral rigid substrate provides nucleation points for the precipitated DNA to form aggregates. The DNA aggregates can interact with the polyhedral rigid substrate by any suitable mechanism, such as charge interactions, adsorption, chelation, etc. between DNA and substrate surface molecules.
[0060] Any suitable washing buffer and washing scheme can then be used to wash this type of aggregate. Washing buffer generally includes alcohol (e.g., ethanol), and helps to remove salt and other ions from the biological sample, while the precipitated DNA is aggregated on the surface of the substrate. After adding washing buffer, the sample can be centrifuged to collect the undesirable components (e.g., protein, salt, etc.) that can be removed from the sample. The sample can then be resuspended in the washing buffer, and the process is repeated one or more times (e.g., 1,2,3,4 times or more). The inventor has recognized and understood that the interaction between the polyhedral rigid substrate and the precipitated DNA has reduced the mechanical shearing of the DNA during the washing sample by reducing the contact point between the substrate and the microcentrifuge wall.
[0061] After the final volume of wash buffer has been removed from the cells, the precipitated DNA can be eluted from the polyhedral rigid substrate by contacting the DNA with any suitable elution buffer. Examples of suitable elution buffers include water (e.g., nuclease-free water), Tris buffer, Tris-EDTA (TE) buffer, acetate buffer (e.g., ammonium acetate, etc.), or other low ionic strength buffers. In some embodiments, the elution buffer comprises or consists of spermine. When the isolated DNA is to be used in another library preparation technique, such as a technique that includes the use of certain enzymes, such as transposases or polynucleotide binding proteins, spermine is generally a preferred eluent. The eluted DNA can be referred to as isolated DNA.
[0062] The polyhedral rigid substrates described in the present disclosure can also be used to purify DNA extracted by methods that do not include the use of polyhedral rigid substrates (eg, DNA previously extracted using glass beads or solution phase techniques).
[0063] In some embodiments, the total mass of the sample of extracted or purified DNA (e.g., HMW gDNA) is at least 100-20000 ng (e.g., 100-20000 ng, 500-15000 ng, 800-10000 ng, 1000-15000 ng, 1000-10000 ng, 1000-8000 ng, 1000-6000 ng, or 1000-2000 ng). In some embodiments, the total mass of the sample of extracted DNA is at least 1000-2000 ng. In some embodiments, the acceptable total DNA amount for further sequencing is at least 20-200 ng (e.g., 20-200 ng, 30-200 ng, or 50-150 ng). In some embodiments, the amount of total DNA (eg, HMW gDNA) of interest for further sequencing is greater than 30-200 ng (eg, 30-200 ng, 50-200 ng, or 100-200 ng).
[0064] In some embodiments, the target purity of a sample of extracted or purified DNA (e.g., HMW gDNA) corresponds to a range of a ratio of absorbance at 260 nm to absorbance at 280 nm of at least 1.8-2 (e.g., at least 1.8-2, at least 1.8-1.9). In some embodiments, the purity of the extracted or purified DNA sample corresponds to a ratio of absorbance at 260 nm to absorbance at 280 nm of at least 1 (e.g., at least 1, at least 1.2, at least 1.4, at least 1.6, at least 1.8, or at least 2). In some embodiments, an acceptable purity of an extracted or purified DNA sample corresponds to a ratio of absorbance at 260 nm to absorbance at 280 nm of at least 1.5 (e.g., at least 1.5, at least 1.7, at least 2). In some embodiments, the purity of a DNA sample extracted or purified as described herein is analyzed by a spectrophotometer, such as a small volume full spectrum UV-visible spectrophotometer (eg, a Nanodrop spectrophotometer available from ThermoFisher Scientific).
[0065] Aspects of the present disclosure relate to nucleic acid sequencing of isolated DNA (e.g., HMW gDNA) extracted and / or purified according to the methods described herein. In some embodiments, one or more additional sample preparation techniques are performed on isolated DNA (e.g., HMW gDNA) produced according to the methods described herein. For example, in some embodiments, the isolated DNA is used as input to a library preparation method. Library preparation methods for sequencing are generally known, such as Amarasinghe et al. Opportunities and challenges in long-read sequencing data analysis. Genome Biol 21, 30 (2020).doi.org / 10.1186 / s13059-020-1935-5. In some embodiments, the library preparation protocol comprises an ultra-long DNA sequencing kit protocol (e.g., as described at store.nanoporetech.com / us / ultra-long-dna-sequencing-kit.html, the entire contents of which are incorporated herein by reference).
[0066] Library preparation techniques typically include connecting adapters to isolated nucleic acids (e.g., isolated HMW gDNA). In some embodiments, the isolated DNA (e.g., HMW gDNA) template is modified to include Y adapters at both ends. Any modification can be used. The method can include contacting DNA (e.g., HMW gDNA) with a transposase (e.g., MuA transposase) and a double-stranded transposase substrate population by adding adapters and / or anchors (e.g., tethers) such as Y adapters. The DNA (e.g., HMW gDNA) is modified by transposase (e.g., MuA transposase) and a double-stranded transposase substrate population. The transposase fragments the DNA (e.g., HMW gDNA) and connects the substrate to one or both ends of the fragment. This produces a plurality of modified DNA templates comprising adapters or anchors. The modified DNA template can then be studied. Examples MuA-based methods are disclosed in WO 2015 / 022544 and WO 2016 / 059363 and WO2015 / 150786, the entire contents of each of which are incorporated herein by reference.
[0067] The sequencing adapter may comprise a loading site for loading a polynucleotide binding protein. The loading site may be, for example, a single-stranded region that can be targeted by a polynucleotide binding protein.
[0068] The polynucleotide binding protein, if present, may be provided on a sequencing adaptor. WO 2015 / 110813 and WO 2020 / 234612 describe loading a polynucleotide binding protein onto a target polynucleotide such as an adaptor and are incorporated herein by reference in their entirety, the entire contents of each of which are incorporated herein by reference.
[0069] Nucleic acid sequencing
[0070] Aspects of the present disclosure relate to methods for sequencing isolated nucleic acids (e.g., HMWgDNA) obtained from biological samples from subjects. In some embodiments, sequencing comprises long read or ultra-long read sequencing techniques. However, the skilled person recognizes that isolated DNA extracted or purified according to the methods described herein can also be used for short read sequencing techniques.
[0071] Any suitable sequencing technology and / or equipment can be used to obtain sequencing data from a biological sample. In some embodiments, the sequencing equipment used to sequence the biological sample can be selected from any suitable known sequencing equipment, including but not limited to Illumina, SOLid, Ion Torrent, PacBio, nanopore-based sequencing equipment (e.g., Oxford Nanopore Technologies PLC sequencing equipment, such as MinION, GridION, PromethION), Sanger sequencing equipment, or 454TM sequencing equipment.
[0072] Reagent test kit
[0073] Aspects of the present disclosure relate to a kit comprising a polyhedral rigid substrate as described herein. The kit may additionally comprise one or more other reagents or instruments that enable any of the embodiments mentioned above to be implemented. Such reagents or instruments include one or more of the following: a suitable buffer (aqueous solution), a device for obtaining a sample from a subject (such as a container or instrument comprising a needle), a device for amplifying and / or expressing polynucleotides, a membrane or voltage or patch clamp device as defined above. The reagent may be present in a dry state in the system or kit so that the fluid sample is used to resuspend the reagent. The system or kit may also optionally include instructions that enable the system or kit to be used in the methods described herein or details about which organism the method may be used for. The system or kit may include a magnet or an electromagnet. The system or kit may optionally include nucleotides. In some embodiments, the kit further comprises components of an ultra-long DNA sequencing kit of Oxford Nanopore Technologies Public Limited, including a lysis buffer, a linker population, a fragmentation mixture (e.g., a solution comprising a transposase) and one or more buffers.
[0074] The following examples illustrate the present invention. It should be understood that although specific embodiments, specific configurations, and materials and / or molecules have been discussed herein for methods according to the present invention, various changes or modifications may be made in form and detail without departing from the scope and spirit of the present invention. The following examples are provided to better illustrate specific embodiments and should not be construed as limiting the present application. The present application is limited only by the claims.
[0075] Examples
[0076] Example 1
[0077] This example describes one embodiment of a polyhedral rigid substrate. Figure 1The substrate shown in comprises a regular star-shaped stainless steel substrate that binds to nucleic acid (eg, DNA) present in a biological sample.
[0078] The substrate has five points. The outer angle between each point is about 72 degrees, and the inner angle of each point is about 54.3 degrees. The diameter of the substrate (e.g., the distance between two opposite points of the star shape) is about 6 mm and the thickness is about 0.5 mm. The substrate is a solid piece of 316 stainless steel, and each edge of the stainless steel is substantially smooth (e.g., without burrs and sharp edges). In certain embodiments, the surface of the substrate is acid etched. The polyhedral substrate is superior to the circular substrate described previously because the polyhedral substrate does not have as many contraction points formed in the bottom of the micropore as the circular substrate does in the bottom of the micropore. The reduction in the number of contraction points reduces DNA shearing during DNA extraction, purification and sequencing library preparation (or any other technology involving DNA dissolved by rotation or centrifugation).
[0079] The polyhedral substrate is rigid, meaning that the substrate is made of a material that does not flex or bend during pipetting or during centrifugation (e.g., the flexibility of the substrate is less than that of shapes made of cellulose filter paper). The rigid substrate will not spin all the way to the bottom of a sample preparation container (e.g., a microcentrifuge tube such as an Eppendorf tube), and thus can allow recovery of semi-eluted nucleic acids (e.g., DNA).
[0080] Example 2
[0081] This example describes one embodiment of a protocol for extracting genomic DNA (gDNA) using the polyhedral rigid substrates described in the present disclosure. In a sample preparation tube (e.g., a 1.5 mL Eppendorf tube), a homogenate containing cells and / or tissue is lysed using a surfactant and proteins are denatured using guanidine hydrochloride.
[0082] Next, a polyhedral rigid substrate (e.g., a 5 mm stainless steel star) is added to the lysate. DNA (including gDNA) is then precipitated from the solution using isopropyl alcohol (ISOP). As the gDNA precipitates, it nucleates around the polyhedral rigid substrate (e.g., a metal star) and aggregates at the surface of the substrate ( Figure 2 ). The gDNA can then be washed while interacting with (e.g., bound to or aggregated on) the substrate, or eluted from the substrate into a buffer of choice, such as water, isopropanol, or spermine.
[0083] Subsequent additional sample preparation techniques, such as fragmentation, ligation of adapters for sequencing, etc. can be performed on the eluted gDNA. When preparing samples for nanopore-based sequencing, it is preferred to precipitate the gDNA from solution using a combination of spermine (or equivalents, such as other polyamines or polycations) and metal stars, as ISOP can denature molecular motors or other proteins used in downstream preparation of gDNA for sequencing.
[0084] One advantage of using non-circular substrates (e.g., polyhedral rigid substrates) for DNA extraction and purification is that, unlike circular solid substrates, polyhedral rigid substrates do not form structural points that force DNA (e.g., gDNA) to pass through during precipitation and washing steps that typically include centrifugation. These constriction points have been observed ( Figure 3 , arrows) facilitate the shearing of DNA (including gDNA), resulting in the isolation of shorter DNA fragments from the sample. When performing nucleic acid sequencing, shorter DNA fragments are one reason for the reduction in read length. Figure 4 Representative data indicating read length N50 from a sequencing run (read N50 refers to the value at which half of the data is contained within reads of length greater than this length; thus N50 is the length of a set of sequences where the sum of all sequences of that length or longer is 50% of the total size of the set) are shown, where a DNA library was cleaned using a rigid polyhedral substrate (e.g., a metal star shape) as described herein. The data indicate that the star-shaped substrate appears to protect the DNA from shearing, whereas extraction of the circular-shaped substrate results in DNA shearing.
[0085] Example 3
[0086] This example provides an example of a workflow for preparing high molecular weight (HMW) DNA from biological samples for nanopore-based sequencing. In some embodiments, wide-bore pipette tips are used for all pipetting and mixing steps. ®HMW DNA Extraction Kit (New England Biolabs, USA; neb.com / products / t3060-monarch-hmw-dna-extraction-kit-for-tissue#Product%20Information; accessed on May 17, 2022). The extracted gDNA is purified and subsequently ligated to sequencing adapters using an ultra-long DNA sequencing kit (Oxford Nanopore Technologies PLC, UK; store.nanoporetech.com / us / ultra-long-dna-sequencing-kit.html; accessed on May 17, 2022) combined with a polyhedral rigid substrate (e.g., metal star) as described in the present disclosure.
[0087] DNA extraction:
[0088] 1. Prepare 1800 μL Monarch HMW gDNA Tissue Lysis Buffer + 60 μL Proteinase K in a 2 mL tube
[0089] 2. Take 6e6 cells from the cell culture (e.g. GM24385 (10e6 / ml) = 600 ul for 6e6 cells).
[0090] 3. Transfer the cells to a 5 mL tube.
[0091] 4. Obtain the pellet by centrifugation at 500 x g for 3 minutes
[0092] 5. Remove the supernatant, trying not to disturb the cell pellet.
[0093] 6. Resuspend in 40 μL PBS and flick to mix.
[0094] 7. Add 1800 μL of lysis buffer and proteinase K buffer.
[0095] 8. Mix 5x using a wide bore pipette.
[0096] 9. Add 15 μL RNase A. Mix 5x using wide pore size.
[0097] 10. Heat to 56°C and shake at 650 rpm for 10 minutes.
[0098] 11. Add 900 μL of Monarch Protein Isolation Solution without mixing. Mix for 10 minutes using a Hula mixer at the lowest speed where the mixer motion is smooth). This step is necessary for tissue extractions but not for all cell lines.
[0099] 12. Centrifuge at 16,000 g for 10 min at 4 °C to separate protein and DNA.
[0100] 13. Aspirate the upper phase containing DNA, leaving the lower phase containing protein, being careful not to aspirate any of the lower phase, and dispense it into a new 5 mL tube.
[0101] 14. Add 3X glass beads to the tube (one will remain at the bottom of the tube).
[0102] 15. Add 2500 μL of isopropanol to the tube and mix on a Hula mixer for approximately 20 minutes.
[0103] 16. Remove the isopropanol supernatant, making sure not to remove any DNA bound to the beads. Remove any isopropanol that may be stuck in the lid.
[0104] 17. Wash with 2 mL Monarch gDNA Wash Buffer.
[0105] 18. Remove the wash buffer.
[0106] 19. Wash with 2 mL Monarch gDNA Wash Buffer.
[0107] 20. Set up a 2 mL tube with 560 µL of EEB (e.g., TE pH 9.0, 0.02% EcoSurf).
[0108] 21. Discard most of the wash buffer, and then transfer the remaining wash buffer and glass beads to a spin column.
[0109] 22. Use a benchtop centrifuge to spin down gradually to remove residual wash buffer.
[0110] 23. Transfer the glass beads from the bead holder to the tube containing EEB for elution.
[0111] 24. Heat at 56°C for 10 minutes.
[0112] 25. Remove beads from EEB and hold EEB by pouring beads into a bead holder in a 2 mL tube, swirling to remove any EEB remaining on the beads.
[0113] 26. Discard the glass beads and holder, then add an additional 200 μL of EEB for elution.
[0114] 27. Incubate overnight at room temperature.
[0115] Purification and library preparation:
[0116] 1. Combine 6 μL of FRA with 244 μL of FDB and mix thoroughly.
[0117] 2. Add 250 μL of FRA / FDB to 750 μL of gDNA and mix gradually.
[0118] 3. Incubate at room temperature for 10 minutes.
[0119] 4. Incubate at 75°C for 10 minutes to inactivate protein complexes (such as transposome complexes).
[0120] 5. Cool on ice.
[0121] 6. Add 5 μL of poly-TRAP, gradually and mix thoroughly.
[0122] 7. Incubate at room temperature for 30 minutes.
[0123] 8. Add the metal star.
[0124] 9. Add 500 μL of PPT reagent. 20 mM spermine.
[0125] 10. Spin on low speed in a hula blender for 20 minutes.
[0126] 11. Remove the supernatant, leaving enough volume so that the metal stars are still suspended.
[0127] 12. Pour the metal stars and remaining supernatant into a 1.5 mL tube.
[0128] 13. Remove the remaining supernatant from underneath the stars.
[0129] 14. Spin gradually to remove residual supernatant in a benchtop centrifuge.
[0130] 15. Use a pipette to remove the remaining supernatant from the bottom of the tube.
[0131] 16. Add 225 μL of EB and let stand to resuspend overnight.
[0132] After extraction, purification, and library preparation, the nucleic acid sample is loaded into a nanopore sequencing flow cell (e.g., FLO-MIN106D, FLO-MIN111, FLO-PRO002; Oxford Nanopore Technologies Public Ltd., UK), for example, according to the following protocol. The sample is then run on a sequencing device, such as MinION, GridION, PromethION, etc.
[0133] Flow cell loading
[0134] 1. Use a pipette to aspirate as many EBs as possible from the tube containing the stars into a new 1.5 mL tube.
[0135] 2. Spin the tubes at reduced speed in a benchtop centrifuge.
[0136] 3. Remove all liquid from the tube and make sure no liquid remains on the metal star.
[0137] 4. Mix the sample thoroughly using a wide bore pipette tip.
[0138] 5. Take 75 μL of sample into a new tube and add 75 μL of SQB, mix thoroughly with a wide-bore pipette.
[0139] 6. Leave to incubate at room temperature for 30 minutes.
[0140] 7. Load the priming mix into the R9.4.1 PromethION flow cell (1170 μL of FB and 30 μL of priming tether per flow cell).
[0141] 8. Load the entire 150 μL library using a wide-bore pipette.
[0142] 9. Run on sequencing equipment.
Claims
1. A method for isolating nucleic acids from a biological sample, the method comprising: (a) obtaining a biological sample, wherein the biological sample comprises nucleic acid; (b) contacting the biological sample with a polyhedral rigid substrate; (c) adsorbing the nucleic acid of the sample onto the polyhedral rigid substrate; (d) washing the polyhedral rigid substrate to remove non-nucleic acid components of the biological sample; (e) releasing the nucleic acid from the polyhedral rigid substrate to produce nucleic acid isolated from the biological sample.
2. The method of claim 1, wherein the nucleic acid comprises DNA, optionally wherein the DNA is genomic DNA (gDNA).
3. The method of claim 1 or 2, wherein the nucleic acid comprises high molecular weight (HMW) DNA.
4. The method of claim 3, wherein the HMW DNA comprises at least 30 kb.
5. The method of any one of claims 1 to 4, wherein the HMW DNA comprises a DNA of at least 50 kb in size, a DNA of at least 100 kb in size, a DNA of at least 200 kb in size, a DNA of at least 300 kb in size, a DNA of at least 500 kb in size, or a DNA of at least 1 Mb in size.
6. The method according to any one of claims 1 to 5, wherein the biological sample comprises a tissue sample, a blood sample, a tissue lysate or a cell lysate. The method according to claim 6 , wherein the tissue lysate or cell lysate has been previously obtained from the biological sample. 8 . The method according to claim 1 , wherein obtaining the biological sample comprises lysing cells or tissues of the biological sample to produce a cell lysate or a tissue lysate.
9. The method of any one of claims 1 to 9, wherein the polyhedral rigid substrate comprises 4 to 50 faces.
10. The method according to any one of claims 1 to 9, wherein the polyhedral rigid substrate comprises 12 faces.
11. The method according to any one of claims 1 to 10, wherein the polyhedral rigid substrate forms a regular shape.
12. The method according to any one of claims 1 to 11, wherein the polyhedral rigid substrate forms an irregular shape.
13. The method according to any one of claims 1 to 12, wherein the polyhedral rigid substrate forms a star shape.
14. The method according to any one of claims 1 to 11, wherein the star shape is a regular star shape.
15. The method of claim 13 or 14, wherein the star shape comprises five points.
16. The method of any one of claims 13 to 15, wherein each exterior angle of the star shape is between 71 and 73 degrees.
17. The method of any one of claims 13 to 16, wherein each interior angle of each point of the star shape is between 53 and 56 degrees.
18. The method of any one of claims 1 to 17, wherein each edge of the polyhedral rigid substrate is substantially smooth.
19. The method of any one of claims 1 to 18, wherein the outer diameter of the polyhedral rigid substrate is between about 5 mm and about 7 mm in length.
20. The method according to any one of claims 1 to 19, wherein the outer diameter of the polyhedral rigid substrate is 6 mm in length.
21. The method according to any one of claims 1 to 20, wherein the thickness of the polyhedral rigid substrate is between 0.1 mm and 0.5 mm.
22. The method of any one of claims 1 to 21, wherein the polyhedral rigid substrate comprises or consists of a metal.
23. The method of claim 22, wherein the metal comprises stainless steel, optionally wherein the stainless steel is 304 stainless steel, 316 stainless steel, 420 stainless steel, or 440 stainless steel.
24. The method of any one of claims 1 to 23, wherein adsorbing the nucleic acids of the sample onto the polyhedral rigid substrate comprises providing conditions in which the nucleic acids of the sample nucleate on the surface of the substrate and form one or more nucleic acid aggregates.
25. The method of claim 24, wherein the conditions comprise contacting the biological sample with isopropanol, spermine, water, or TE buffer.
26. The method of any one of claims 1 to 25, wherein washing comprises centrifuging the biological sample after contacting the biological sample with a wash buffer.
27. The method of any one of claims 1 to 26, wherein the non-nucleic acid components removed from the biological sample comprise one or more proteins, RNA molecules, salts, carbohydrates or other cellular debris.
28. The method of any one of claims 1 to 27, wherein releasing the nucleic acid from the substrate comprises contacting the substrate with isopropanol, spermine, water, or TE buffer.
29. The method of any one of claims 1 to 28, wherein the isolated nucleic acid comprises or consists of genomic DNA (gDNA).
30. The method of any one of claims 1 to 29, wherein the isolated nucleic acid comprises or consists of high molecular weight (HMW) DNA, optionally wherein the HMW DNA comprises DNA of at least 30 kb in size.
